7 completed, 2 recruiting, 1 active not recruiting. 10 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 7, Recruiting 2, Active not recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Placebo Oral Solution: new trials by email Literature Review of Placebo Oral Solution trials Research Report on Placebo Oral Solution
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects TLC-1180 Oral Solution, TLC-1180 Tablet, Placebo Oral Solution - Healthy Participants | Phase 1 | Recruiting | OrsoBio, Inc | 332 | 2025-10-20 | 2026-08-21 |
| CBD for Pain Following Orthopedic Shoulder Surgery Epidiolex, Placebo oral solution - Shoulder Osteoarthritis, Rotator Cuff Injuries | Phase 1 / Phase 2 | Recruiting | The Methodist Hospital Research Institute | 80 | 2024-05-24 | 2026-04-16 |
| Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes TLC-6740 Oral Solution, Placebo Oral Solution, TLC-6740 Tablet - Healthy Subjects, Obesity | Phase 1 | Active not recruiting | OrsoBio, Inc | 564 | 2023-04-22 | 2026-08-21 |
| Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder Cannabidiol (CBD) oral solution, Placebo, Massed Prolonged Exposure (mPE) - Posttraumatic Stress Disorder, Stress Disorders, Post-Traumatic | Phase 1 / Phase 2 | Completed | The University of Texas Health Science Center at San Antonio | 21 | 2022-04-04 | 2024-10-10 |
| Single and Multiple-Ascending Dose Study of CRN04894 in Healthy Volunteers CRN04894 Oral Solution, Placebo Oral Solution - Healthy Volunteers | Phase 1 | Completed | Crinetics Pharmaceuticals Inc. | 88 | 2020-12-18 | 2023-09-21 |
| A Phase 1 Study of SMP-100 in Normal Healthy Volunteers SMP-100, Placebo - Healthy Volunteers | Phase 1 | Completed | Chengdu SciMount Pharmatech Co., Ltd. | 53 | 2020-06-25 | 2022-03-11 |
| Study on the Safety of the Drug BAY2395840 at Different Doses, the Way the Body Absorbs, Distributes and Excretes the Drug Including the Effect of Its Formulation (Tablet or Liquid) and the Effect of Food on the Absorption, Distribution or Excretion of the Drug in Healthy Male Participants BAY2395840 tablet, BAY2395840 oral solution, Placebo oral solution - Endometriosis | Phase 1 | Completed | Bayer | 63 | 2019-12-18 | 2022-08-26 |
| A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970 GLPG3970 oral solution, Placebo oral solution, GLPG3970 capsule - Healthy, Psoriasis | Phase 1 | Completed | Lakefront Biotherapeutics NV | 100 | 2019-09-10 | 2024-09-19 |
| A Single and Multiple-Ascending Dose Study of CRN01941 in Healthy Adult Volunteers CRN01941 Oral Solution, CRN01941 Oral Capsule, Placebo Oral Solution - Healthy Volunteers | Phase 1 | Completed | Crinetics Pharmaceuticals Inc. | 57 | 2019-04-29 | 2020-11-04 |
| Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers CRN00808, Placebo Oral Solution, Midazolam oral solution - Healthy Volunteers | Phase 1 | Completed | Crinetics Pharmaceuticals Inc. | 99 | 2017-09-22 | 2018-08-29 |
Diabetes Mellitus, Type 2 (1) · Endometriosis (1) · Obesity (1) · Psoriasis (1) · Rotator Cuff Injuries (1) · Stress Disorders, Post-Traumatic (1)
Crinetics Pharmaceuticals Inc. (3) · OrsoBio, Inc (2) · Bayer (1) · Chengdu SciMount Pharmatech Co., Ltd. (1) · Lakefront Biotherapeutics NV (1) · The Methodist Hospital Research Institute (1) · The University of Texas Health Science Center at San Antonio (1)
Australia (3) · United States (3) · New Zealand (2) · Belgium (1) · Germany (1) · Moldova (1) · Ukraine (1)
Casey Straud, PsyD (1) · Jason Lickliter, MBBS PhD (1) · Magdalena Petkova, MD (1) · Patrick McCulloch, MD (1) · Sepehr Shakib (1)
2019 (2), KL2TR002646 (1), UL1TR002645 (1)